Literature DB >> 125117

Bone marrow and thymus transplantation in ataxia-telangiectasia.

R H Buckley.   

Abstract

Serum IgA concentrations were found to be normal in a boy with ataxia-telangiectasia and selective IgA deficiency several months after an infusion of bone marrow cells from an HL-A and MLR compatible normal sib. In addition, transient improvements were noted in both his in vivo and in vitro cellular immune responsiveness through the third month posttransplant. Despite this, no evidence of chimerism could be detected in karyotypic studies of his peripheral blood lymphocytes and bone marrow cells. No clinical or significant immunologic improvement was noted in his affected female sib following implantation of a fetal thymus or injection of transfer factor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 125117

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


  3 in total

1.  Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.

Authors:  J Pietzner; B M Merscher; P C Baer; R P Duecker; O Eickmeier; D Fußbroich; P Bader; D Del Turco; R Henschler; S Zielen; R Schubert
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

2.  Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia.

Authors:  Sujal Ghosh; Friedhelm R Schuster; Vera Binder; Tim Niehues; Stephan E Baldus; Peter Seiffert; Hans-Jürgen Laws; Arndt Borkhardt; Roland Meisel
Journal:  J Clin Immunol       Date:  2012-02-23       Impact factor: 8.542

3.  Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.

Authors:  Sara Di Siena; Federica Campolo; Roberto Gimmelli; Chiara Di Pietro; Daniela Marazziti; Susanna Dolci; Andrea Lenzi; Andre Nussenzweig; Manuela Pellegrini
Journal:  Cell Death Dis       Date:  2018-02-22       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.